CBC Group Secures $500 Million for Asia’s Largest Healthcare-Focused Private Credit Fund

CBC Group Secures $500 Million for Asia’s Largest Healthcare-Focused Private Credit Fund

By USFMOctober 15, 2025

Singapore-based CBC Group has successfully raised $500 million for its second R-Bridge Healthcare Fund, positioning it as the largest healthcare-focused private credit fund in Asia. This significant increase from its first fund reflects a diverse investor base and a strategic focus on non-dilutive financing within the healthcare sector.

CBC Group, a private investment fund headquartered in Singapore, has announced the closure of a $500 million fundraising for its second R-Bridge Healthcare Fund, solidifying its status as Asia's largest healthcare-focused private credit fund. This fundraising represents a 66.7% increase from its inaugural fund, which raised $300 million, signaling a growing interest and trust from a broadened investor base that includes sovereign wealth funds, pension funds, financial institutions, and family offices from across the United States, Europe, Asia, and the Middle East.

The strategic rationale behind this fundraising is CBC's emphasis on non-dilutive financing and royalty-backed structures, which are designed to provide downside protection and immediate cash flow for investors. The fund will be deployed globally, with approximately half of the portfolio earmarked for investments in approved drugs, while the remaining funds will be allocated to approved medical devices and diagnostics. This targeted investment strategy not only aims to maximize returns but also addresses critical healthcare needs, making it an appealing avenue for investors.

As CBC Group continues to manage around $11 billion in assets, the firm is well-positioned to leverage this new capital for strategic investments in the healthcare sector, a field that is increasingly ripe with opportunities given the ongoing global healthcare challenges.

The timeline for deployment of the fund is expected to unfold in the coming months as CBC identifies suitable investment opportunities. Shareholders and stakeholders in the healthcare industry may be watching closely, as this fund could potentially enhance the landscape of healthcare financing in Asia, providing critical support for innovations and advancements in medical technology.

While the filing does not specify any immediate regulatory hurdles, the nature of private credit funding typically requires compliance with various financial regulations. However, given CBC Group's established presence in the investment landscape, navigating these regulatory considerations should be manageable.

In summary, CBC Group's successful $500 million fundraising for its R-Bridge Healthcare Fund marks a significant milestone in private credit for the healthcare sector, with the potential to provide essential capital to innovative healthcare solutions while delivering value to a diverse group of investors.